Dare Bioscience, Inc. Gains 63.89%
Tue, Jan 19, 2021 at 05:30 PM
Dare Bioscience, Inc. (DARE:NASDAQ) rocketted at $2.36, a gain of 63.9%. On Fri 15 Jan 21, DARE:NASDAQ touched a New 2-Week Intraday High of $1.59. The stock got featured on our News Catalysts scanner on Tue 12 Jan 21 at 11:06 AM in the 'MISCELLANEOUS' category. From Mon 04 Jan 21, the stock recorded 55.56% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Dare Bioscience, Inc. (DARE:NASDAQ)
Dare Bioscience Inc is a healthcare company. The company develops and commercializes products in women's reproductive health. Its segment includes spectrum of categories like: contraception, vaginal health, pain and fertility.
Top 10 Gainers:
- Gritstone Oncology, Inc. (GRTS:NASDAQ), 248.51%
- Aclaris Therapeutics, Inc. (ACRS:NASDAQ), 220.24%
- Inuvo, Inc. (INUV:NYSEMKT), 123.01%
- Senseonics Holdings, Inc. (SENS:NYSEMKT), 80.38%
- Gevo, Inc. (GEVO:NASDAQ), 72.34%
- TransEnterix, Inc. (TRXC:NYSEMKT), 68.6%
- ENDRA Life Sciences Inc. (NDRA:NASDAQ), 65.71%
- Dare Bioscience, Inc. (DARE:NASDAQ), 63.89%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 54.87%
- EHang Holdings Limited (EH:NASDAQ), 53.48%